Titelia

Funds holding NEUBASE THERAPEUTICS INC

ISIN US64132K2015 · United States · LEI 529900RHAZB85RGSJZ73

Fund holders
4
Of which ETFs
0 4 other funds
Value held
3.6K $
FundSharesValueWeight in fund
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 11,2162.7K $as of Feb 28, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 1,425337.7 $as of Feb 28, 2026 ↗
Fidelity Total Market Index Fund Fidelity Concord Street Trust 1,359322.1 $as of Feb 28, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 985233.5 $as of Feb 28, 2026 ↗

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q24014,9850.0 %
2026Q14014,9850.0 %
2025Q44014,9850.0 %
2025Q34014,9850.0 %
2025Q24-114,985-55.9 %
2025Q15033,9660.0 %
2024Q45033,9660.0 %
2024Q35033,9660.0 %
2024Q25-133,966-31.5 %
2024Q16-149,621+8.2 %
2023Q4745,841
Cite this page

Titelia. "Funds holding NEUBASE THERAPEUTICS INC". https://titelia.com/en/stocks/neubase-therapeutics-inc-US64132K2015